Danaher Corp (DHR) - Former Life Sciences Revenue (I:DCDHRFLS)
Level Chart
Basic Info
|
Danaher Corp (DHR) - Former Life Sciences Revenue is at a current level of 3.799B, up from 3.534B last quarter and up from 3.292B one year ago. This is a change of 7.50% from last quarter and 15.40% from one year ago. |
|
Danaher Corp Former Life Sciences Revenue refers to the income generated by the company's business activities related to the life sciences sector, which includes products and solutions used in various fields such as biotechnology, pharmaceuticals, diagnostics, and research. |
| Report | Fiscal.ai |
| Category | Segments & KPIs |
| Region | United States |
| Source | Fiscal.ai |
|
Data provided via Fiscal.ai |
Stats
| Last Value | 3.799B |
| Latest Period | Jun 2026 |
| Last Updated | Jul 21 2026, 11:18 EDT |
| Next Release | Oct 20 2026, 08:30 EDT (E) |
| Average Growth Rate | 14.42% |
| Value from Last Quarter | 3.534B |
| Change from Last Quarter | 7.50% |
| Value from 1 Year Ago | 3.292B |
| Change from 1 Year Ago | 15.40% |
| Frequency | Quarterly |
| Unit | USD |
| Adjustment | N/A |
| Download Source File |
Historical Data
| Date | Value |
|---|---|
| June 26, 2026 | 3.799B |
| March 27, 2026 | 3.534B |
| December 31, 2025 | 4.118B |
| September 26, 2025 | 3.59B |
| June 27, 2025 | 3.627B |
| March 28, 2025 | 3.292B |
| December 31, 2024 | 3.901B |
| September 27, 2024 | 3.435B |
| June 28, 2024 | 3.483B |
| March 29, 2024 | 3.269B |
| December 31, 2023 | 3.689B |
| September 29, 2023 | 3.37B |
| June 30, 2023 | 3.681B |
| March 31, 2023 | 3.573B |
| Date | Value |
|---|---|
| December 31, 2022 | 4.169B |
| September 30, 2022 | 3.776B |
| July 01, 2022 | 3.967B |
| April 01, 2022 | 3.882B |
| December 31, 2021 | 4.046B |
| October 01, 2021 | 3.632B |
| July 02, 2021 | 3.734B |
| April 02, 2021 | 3.546B |
| December 31, 2020 | 3.361B |
| October 02, 2020 | 2.923B |
| July 03, 2020 | 2.642B |
| April 03, 2020 | 1.65B |
| December 31, 2019 | 1.916B |
News
Basic Info
|
Danaher Corp (DHR) - Former Life Sciences Revenue is at a current level of 3.799B, up from 3.534B last quarter and up from 3.292B one year ago. This is a change of 7.50% from last quarter and 15.40% from one year ago. |
|
Danaher Corp Former Life Sciences Revenue refers to the income generated by the company's business activities related to the life sciences sector, which includes products and solutions used in various fields such as biotechnology, pharmaceuticals, diagnostics, and research. |
| Report | Fiscal.ai |
| Category | Segments & KPIs |
| Region | United States |
| Source | Fiscal.ai |
|
Data provided via Fiscal.ai |
Stats
| Last Value | 3.799B |
| Latest Period | Jun 2026 |
| Last Updated | Jul 21 2026, 11:18 EDT |
| Next Release | Oct 20 2026, 08:30 EDT (E) |
| Average Growth Rate | 14.42% |
| Value from Last Quarter | 3.534B |
| Change from Last Quarter | 7.50% |
| Value from 1 Year Ago | 3.292B |
| Change from 1 Year Ago | 15.40% |
| Frequency | Quarterly |
| Unit | USD |
| Adjustment | N/A |
| Download Source File |
Related Securities
Related Indicators
| Danaher Corp (DHR) - Biotechnology Operating Income | 556.00M USD |
| Danaher Corp (DHR) - Biotechnology Revenue | 1.92B USD |
| Danaher Corp (DHR) - Core Sales Growth | 3.00% |
| Danaher Corp (DHR) - Diagnostics Operating Income | 416.00M USD |
| Danaher Corp (DHR) - Diagnostics Revenue | 2.466B USD |
| Danaher Corp (DHR) - Former Life Sciences Operating Income | 800.00M USD |
| Danaher Corp (DHR) - Life Sciences Operating Income | 244.00M USD |
| Danaher Corp (DHR) - Life Sciences Revenue | 1.879B USD |
| Danaher Corp (DHR) - Non-Recurring Revenue | 1.065B USD |
| Danaher Corp (DHR) - Recurring Revenue | 5.20B USD |